-+ 0.00%
-+ 0.00%
-+ 0.00%

Pasithea Therapeutics Unveils Investor Presentation Highlighting Next-Generation MEK Inhibitor PAS-004 for Cancer and NF1

Reuters·01/13/2026 12:22:02

Please log in to view news